Trial Profile
ACTHAR Therapy for Central Nervous System Sarcoidosis
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2020
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Sarcoidosis
- Focus Therapeutic Use
- 19 Nov 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 19 Nov 2020 Planned End Date changed from 1 Dec 2020 to 2 Nov 2020.
- 19 Nov 2020 Planned primary completion date changed from 1 Jul 2020 to 2 Nov 2020.